ClinicalTrials.gg
Enrolling by invitationNCT07682051PTGRAZ_26/27Updated Sep 9, 2026

Effects of Resistance Training on Patellar Tendon Properties in People With Patellar Tendinoapthy

An interventional study of Eccentric Training and Heavy-Slow Resistance Training in Patellar Tendinopathy, sponsored by University of Graz. Enrolling by invitation at 1 site in Austria. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by University of Graz · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This study aims to investigate the effects of two different resistance training interventions on the structural, morphological, mechanical, and functional properties of the thigh muscles (in particular the quadriceps femoris) and the patellar tendon, in participants with current patellar tendinopathy.

Read the detailed description

Patellar tendinopathy is a common musculoskeletal injury among physically active people and athletes, particularly those who play sports that involve high jumps, such as volleyball and basketball. This condition is associated with alterations in the intrinsic properties of the muscle (e.g., cross-sectional area, muscle length) and the patellar tendon (e.g., stiffness, thickness), along with impairments in sports performance (e.g., altered jump height) and tendon pain.

The current gold-standard treatment for tendinopathies is composed mainly of eccentric training, which overall shows a good percentage of remission of the symptoms, but on the other hand, a high percentage of recurrence of said symptoms.

The objectives are to find out if a specific and controlled eccentric training and heavy-slow resistance training, which literature has shown to be a friendly and closer to daily-life movement alternative for management of patellar tendinopathy. Through the assessment of several muscle, tendon, and performance parameters, our study aims to investigate if individually targeted training variables on both training interventions show a better improvement in the intrinsic properties of the anatomical structures, as well as functional and performance parameters like pain level, strength, jump height, etc.

02

Conditions studied

  • Patellar Tendinopathy

Browse trials for

03

In context

Tendinopathy

399 studies on the registry are indexed under Tendinopathy; 77 are open to participants now.

This study's planned enrollment of 30 is below the median of 48 across 333 interventional studies indexed under Tendinopathy.

Browse Tendinopathy studies →

Lead sponsor

University of Graz is the lead sponsor of 6 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between 18 and 50 years of age
  • Pain at the inferior pole of the patella, longer than 3 months
  • Active lifestyle (sport/exercise minimum 3 times per week)
  • No previous injuries or surgeries on the affected leg

Exclusion criteria

Exclusion Criteria:

  • Corticoid injections in the last 6 months
  • Current intake of pain or non-steroidal anti-inflammatory drugs
  • Additional tendinopathy treatments in the last 6 months (i.e., physical therapy, shock-wave therapy, drug interventions, etc.)
  • Neuromuscular or cardiovascular associated diseases or conditions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Eccentric Training

    Participants between 18 and 50 years of age with patellar tendinopathy who will receive the eccentric intervention only.

    Other: Eccentric Training

  • Experimental
    Heavy-Slow Resistance Training

    Participants between 18 and 50 years of age with patellar tendinopathy who will receive the heavy-slow resistance training intervention only.

    Other: Heavy-Slow Resistance Training

Interventions

  • OtherEccentric Training

    The intervention consists of 12 weeks of resistance training, with a frequency of three times per week. Participants in this group will perform two exercises on a leg press and knee extension machine at their own training facility. This intervention has a repetition time of four seconds, with only the eccentric phase of the movement being performed. They will rest between two and three minutes between sets and will perform the exercises as long as their pain level is less than or equal to four on a pain scale from 0-10. The training parameters are the following, applying to both leg press and knee extension exercises: Week 1: 3 sets of 15 repetitions at 60% of their 1-repetition maximum (1RM) Week 2 and 3: 3 sets of 12 repetitions at 70% of their 1RM Week 4 and 5: 3 sets of 10 repetitions at 75% of their 1RM Week 6 to 12: 4 sets of 8 repetitions at 80% of their 1RM.

    Also known as: ECC

  • OtherHeavy-Slow Resistance Training

    The intervention consists of 12 weeks of resistance training, with a frequency of three times per week. Participants in this group will perform two exercises on a leg press and knee extension machine at their own training facility. This intervention has a repetition time of four seconds, of which two seconds will be spent on the concentric phase and two seconds on the eccentric phase of the movement being performed. They will rest between two and three minutes between sets and will perform the exercises as long as their pain level is less than or equal to four on a pain scale from 0-10. The training parameters are the following, applying to both leg press and knee extension exercises: Week 1: 3 sets of 15 repetitions at 60% of their 1-repetition maximum (1RM) Week 2 and 3: 3 sets of 12 repetitions at 70% of their 1RM Week 4 and 5: 3 sets of 10 repetitions at 75% of their 1RM Week 6 to 12: 4 sets of 8 repetitions at 80% of their 1RM.

    Also known as: HSRT

06

What researchers measure

Primary outcomes

  1. Tendon Thickness

    Anteroposterior thickness of the patellar tendon (in milimiters) measures by B-Mode Ultrasound (Aixplorer V12.3 Supersonic Imaging, France) with a SuperLinear 15-4 MHz probe. Three images at the same position will be taken for further analysis with the software ImageJ.

    Time frame: From enrollment to the end of training at 12 weeks

  2. Tendon sitffness

    Stiffness of the patellar tendon (in kilopascal) will be measured with Shear-Wave Elastrography (Aixplorer V12.3, Supersonic Imaging, France). The measurement site is 0.5cm from the patellar apex, and five videos of 15 seconds will be recorded for further analysis with Matlab.

    Time frame: From enrollment to the end of training at 12 weeks

  3. Tendon CSA

    Cross-sectional area of the patellar tendon (in centimiters) on its proximal, middle and distal part, will be measured with B-Mode Ultrasound (Aixplorer V12.3, Supersonic Imaging, France). Three images per site, accounting for a total of 9 images, will be taken for further analysis with the software ImageJ.

    Time frame: From enrollment to the end of training at 12 weeks

  4. Fascicle length

    Length of the fascicles of the vastus lateralis muscle (in centimiters) will be measures with Extended Field of View (Panoramic) B-Mode Ultrasound (Aixplorer V12.3, Supersonic Imaging, France). Five images will be taken for further analysis with the software ImageJ.

    Time frame: From enrollment to the end of training at 12 weeks

  5. Muscle Strength

    Maximum voluntary isometric torque of the knee extensors (in newton per meters) will be measured with the Isomed2000, Germany device. Three trials will be performed, with three minutes of rest in between, and the trial with the maximum peak torque will be taken for analysis.

    Time frame: From enrollment to the end of training at 12 weeks

  6. 1 repetition maximum

    Maximum strength of the leg press and knee extension exercises (in kilograms) will be measured with the leg press and knee extension devices (compass540, Physiomed, Germany). Participants will perform repetitions with increasing weights, until they can perform a maximum of eight repetitions with a specific weight. This weight will be then used to estimate their maximum 1RM, to further calculate the training loads.

    Time frame: From enrollment to the end of training at 12 weeks

  7. Overall Pain

    Pain assessed at rest and during a single-leg-decline squat (SLDS) will be assessed with the numerical rating scale of 11 points called Visual Analogue Scale (VAS). Higher values mean higher pain levels.

    Time frame: From enrollment to the end of training at 12 weeks

  8. Functionality

    Functionality assessed with the VISA-P Questionnaire. This questionnaire includes 10 questions with a score from 0 to 10, for a maximum questionnaire score of 100 points. Higher scores mean better functionality.

    Time frame: From enrollment to the end of training at 12 weeks

Secondary outcomes

  1. Tendon Neovascularization

    Presence of blood vessels in the patellar tendon will be analysed with Color Doppler Ultrasound (MyLab60, Esaote S.p.A., Italy). The measurement site is 0.5cm from the patellar apex. Five videos of 15 seconds each will be taken for further analysis with Matlab.

    Time frame: From enrollment to the end of training at 12 weeks

  2. Young's Modulus

    Tendon Young's Modulus (in kilopascal) will be assessed with Shear-Wave Elastography (Aixplorer V12.3, Supersonic Imaging, France).

    Time frame: From enrollment to the end of training at 12 weeks

  3. Muscle Thickness

    Thickness of the vastus lateralis muscle (in centimiters) will be obtained with Extended Fielv of View Panoramic Ultrasound (Aixplorer V12.3, Supersonic Imaging, France). Five images will be taken, and muscle thickness will be measures on three places on the thickest part of the muscle, and averaged for further analysis with ImageJ.

    Time frame: From enrollment to the end of training at 12 weeks

  4. Muscle Stiffness

    Stiffness of the vastus lateralis tendon (in kilopascal) will be measured with Shear-Wave Elastrography (Aixplorer V12.3, Supersonic Imaging, France). The measurement site is 60% of the length of the muscle, from the greater trochanter to the lateral femur condyle. Five videos of 15 seconds will be recorded for further analysis with Matlab.

    Time frame: From enrollment to the end of training at 12 weeks

  5. Jump Height

    Height of the Countermovement Jump measured with Kinvent Force Plates will be assessed. The participants will perform three jumps with two minutes rest in between them.

    Time frame: From enrollment to the end of training at 12 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Metrics obtained from the outcome variables. No personal information will be shared (e.g., name, gender, anthropometrics)

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: The IPD and supporting information will be available starting June 2026, archived and available to the specific members mentioned above for a period of 10 years (June 2036).

Access criteria: The supervisor and the senior postdoctoral researcher will have access to the information. They will have access to the metrics of the outcome variables of each participant. This includes: tendon stiffness, tendon thickness, tendon cross-sectional area, tendon neovascularization, tendon Young's modulus, muscle thickness, muscle stiffness, fascicle length, strength test results, jump height, pain scores, and questionnaire scores. They will have access through a secure University server that stores the data under the principal investigator's name, which allows selective access to specified people.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Jun 2027, 11 months after the start.

Of 174 non-industry interventional studies with no phase under Tendinopathy, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 38. This study's planned 11 months is below that.

Counting every sponsor, half of 183 studies reached it within 20 months; a quarter within 7 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 23, 2026
First posted
Jul 2, 2026
StartActual
Jul 21, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Nov 30, 2027
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07682051
Lead sponsor
University of Graz
Responsible party
Josefina Manieu (Research Assistant - PhD Student, University of Graz) — Principal investigator
First posted
Jul 2, 2026
Start date
Jul 21, 2026
Primary completion
Jun 30, 2027 (estimated)
Completion
Nov 30, 2027 (estimated)
Last update
Sep 9, 2026

Study contacts

Josefina Manieu Seguel, M.Sc.
principal investigator · University of Graz

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion